Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_assertion type Assertion NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_head.
- NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_assertion description "[To evaluate the toxicity of daily gefitinib, an epidermal growth factor receptor-tyrosine kinase inhibitor, with concurrent chemoradiation (CRT) in patients with locally advanced pancreatic adenocarcinoma and prospectively evaluate plasma k-ras as a potential marker of response to gefitinib and CRT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_provenance.
- NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_assertion evidence source_evidence_literature NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_provenance.
- NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_assertion SIO_000772 19307945 NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_provenance.
- NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_assertion wasDerivedFrom befree-20140225 NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_provenance.
- NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_assertion wasGeneratedBy ECO_0000203 NP763020.RAoTX_AlfSn8BI96K9L6LKg_GRQHyKs32kzhlUMKS5sjs130_provenance.